Following in the footsteps of the other review programs at the US Food and Drug Administration's (FDA) Office of Pharmaceutical Science, the Office of Biotechnology Products (OBP) is currently in ...

With the objective of enhancing quality standards across the sector, the conference will delve into critical topics such as global GMP regulations, risk management, and the integration of Quality by ...